SCHEMBL20040802

SCHEMBL20040802

Nc1ccc(Nc2cc(Cl)ncn2)cc1F

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 1/20 0.52
MKNK1 Q9BUB5 1/20 0.47
SCN9A Q15858 1/20 0.43
MAPK1 P28482 1/20 0.43
EGFR P00533 3/20 0.42
ERBB3 P21860 2/20 0.42
DOT1L Q8TEK3 1/20 0.42
GRM1 Q13255 1/20 0.40
TNNI3K Q59H18 2/20 0.40
POLA1 P09884 1/20 0.40
KMO O15229 1/20 0.40
CDK1 P06493 1/20 0.39
CCNB1 P14635 1/20 0.39
CCNA2 P20248 1/20 0.39
CCNE1 P24864 1/20 0.39
CDK2 P24941 1/20 0.39
CDK5 Q00535 1/20 0.39
CDK5R1 Q15078 1/20 0.39
ROCK2 O75116 1/20 0.38
MEN1 O00255 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2284751 0.86 NPC1 (0.56) NPC1MKNK1SCN9AMAPK1EGFR
SCHEMBL690919 0.81 NPC1 (0.55) NPC1MKNK1MAPK1EGFRERBB3
SCHEMBL22328022 0.79 NPC1 (0.64) NPC1MKNK1SCN9AMAPK1EGFR
SCHEMBL4663995 0.79 NPC1 (0.64) NPC1MKNK1SCN9AEGFRERBB3
SCHEMBL15542527 0.76 NPC1 (0.47) NPC1MKNK1EGFRERBB3TNNI3K
SCHEMBL2283204 0.75 NPC1 (0.68) NPC1MKNK1SCN9AEGFRERBB3
SCHEMBL2279563 0.75 MEN1 (0.56) NPC1MKNK1MAPK1EGFRERBB3
SCHEMBL20093470 0.75 NPC1 (0.51) NPC1MKNK1EGFRERBB3TNNI3K
SCHEMBL1095277 0.74 MAPK1 (0.61) SCN9AMAPK1EGFRERBB3GRM1
Hydrochloric Acid SCHEMBL2176150 0.74 NPC1 (0.66) NPC1MKNK1SCN9AEGFRERBB3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2864289-B1 CYCLOPROPANECARBOXAMIDO-SUBSTITUTED AROMATIC COMPOUNDS AS ANTI-TUMOR AGENTS CB THERAPEUTICS INC (KY) 2018-04-11 EP disclosed